170 related articles for article (PubMed ID: 22983827)
1. Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.
Li K; Li W
Mol Cell Biochem; 2013 Jan; 372(1-2):27-33. PubMed ID: 22983827
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients.
Ke HG; Li J; Shen Y; You QS; Yan Y; Dong HX; Liu JH; Shen ZY
Asian Pac J Cancer Prev; 2012; 13(9):4413-6. PubMed ID: 23167352
[TBL] [Abstract][Full Text] [Related]
3. Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy.
Miao J; Zhang X; Tang QL; Wang XY; Kai L
Asian Pac J Cancer Prev; 2012; 13(10):5007-10. PubMed ID: 23244100
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy.
Ye S; Rong J; Huang SH; Zheng ZS; Yun M; Wang SM
Asian Pac J Cancer Prev; 2012; 13(10):4923-6. PubMed ID: 23244082
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.
Deng JH; Deng J; Shi DH; Ouyang XN; Niu PG
Clin Transl Oncol; 2015 Sep; 17(9):720-6. PubMed ID: 26033426
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis.
Zhai X; Liu J; Hu Z; Wang S; Qing J; Wang X; Jin G; Gao J; Wang X; Shen H
Oncol Rep; 2006 Jan; 15(1):247-52. PubMed ID: 16328064
[TBL] [Abstract][Full Text] [Related]
8. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
Peng Y; Li Z; Zhang S; Xiong Y; Cun Y; Qian C; Li M; Ren T; Xia L; Cheng Y; Wang D
Int J Cancer; 2014 Dec; 135(11):2687-96. PubMed ID: 24729390
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case-control study.
Pan XF; Xie Y; Loh M; Yang SJ; Wen YY; Tian Z; Huang H; Lan H; Chen F; Soong R; Yang CX
Asian Pac J Cancer Prev; 2012; 13(11):5637-42. PubMed ID: 23317230
[TBL] [Abstract][Full Text] [Related]
10. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.
Cheng CX; Xue M; Li K; Li WS
Asian Pac J Cancer Prev; 2012; 13(6):2541-5. PubMed ID: 22938418
[TBL] [Abstract][Full Text] [Related]
12. [Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer].
Wang ZH; Miao XP; Tan W; Zhang XR; Xu BH; Lin DX
Ai Zheng; 2004 Aug; 23(8):865-8. PubMed ID: 15301704
[TBL] [Abstract][Full Text] [Related]
13. [XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Sun Y; Zhang XR; Xu BH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):196-9. PubMed ID: 16875604
[TBL] [Abstract][Full Text] [Related]
14. Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy.
Zhai XH; Huang J; Wu FX; Zhu DY; Wang AC
Oncol Res Treat; 2016; 39(7-8):440-6. PubMed ID: 27487108
[TBL] [Abstract][Full Text] [Related]
15. ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.
Wen YY; Pan XF; Loh M; Tian Z; Yang SJ; Lv SH; Huang WZ; Huang H; Xie Y; Soong R; Yang CX
Asian Pac J Cancer Prev; 2012; 13(5):2139-44. PubMed ID: 22901183
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
Xu C; Wang X; Zhang Y; Li L
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):912-7. PubMed ID: 22152690
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
19. ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy.
Liblab S; Vusuratana A; Areepium N
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1925-1929. PubMed ID: 32711417
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer.
Zhang X; Miao X; Liang G; Hao B; Wang Y; Tan W; Li Y; Guo Y; He F; Wei Q; Lin D
Cancer Res; 2005 Feb; 65(3):722-6. PubMed ID: 15705867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
